Related Experiment Video
Updated: Nov 11, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Predictive value of the atherogenic index of plasma for chronic total occlusion before coronary angiography
Tong Liu1, Jinghua Liu1, Zheng Wu1
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, Chaoyang, China.
Insights
The atherogenic index of plasma (AIP) can help diagnose chronic total occlusion (CTO) and predict its severity. Higher AIP levels are linked to CTO presence and worse outcomes in patients undergoing coronary angiography.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Medical Diagnostics
Background:
- The atherogenic index of plasma (AIP) is derived from triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) levels.
- Previous research links AIP to coronary artery disease, but its role in chronic total occlusion (CTO) needs further investigation.
Purpose of the Study:
- To investigate the diagnostic value of AIP in identifying CTO.
- To assess AIP's potential in predicting adverse events in patients with CTO.
Main Methods:
- A study of 1131 inpatients undergoing coronary angiography.
- Collected data included demographics, Gensini score for stenosis, and Global Registry of Acute Coronary Events/thrombolysis in myocardial infarction (TIMI) scores.
- Calculated AIP using logarithmic transformation of TG/HDL-C ratio and analyzed correlations with clinical parameters and CTO diagnosis via ROC curves.
Main Results:
- The CTO group (n=398) had significantly higher AIP than the control group (n=733).
- AIP positively correlated with body mass index, TIMI score, Gensini score, and stent length.
- Multivariate analysis identified AIP as an independent risk factor for CTO, indicating its predictive value for disease presence and severity.
Conclusions:
- AIP is a valuable biomarker for diagnosing CTO.
- AIP can predict the severity of coronary artery disease and associated risks.
- This index offers potential for improved risk stratification in patients with CTO.
Background:
The atherogenic index of plasma (AIP) is calculated by logarithmic transformation of the ratio of triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) concentrations. Although previous studies have demonstrated that the AIP is associated with coronary artery disease, its association with chronic total occlusion (CTO) requires elucidation.
Hypothesis:
We hypothesized that the AIP would have diagnostic value in cases of CTO and could be used to predict adverse events.
Methods:
This study involved 1131 inpatients who underwent coronary angiography. Data on demographic and clinical characteristics, coronary artery stenosis rated by the Gensini score, and clinical assessment by the Global Registry of Acute Coronary Events and thrombolysis in myocardial infarction (TIMI) scores were collected by cardiovascular doctors. Serum AIP values were evaluated by logarithmic transformation of the ratio of TG and HDL-C concentrations. The correlations of AIP values with clinical parameters were assessed, and receiver-operating characteristic curves were constructed for CTO diagnosis.
Results:
Overall, 1131 inpatients were assigned to the CTO (n = 398) and control (n = 733) groups. Compared with the control group, the CTO group showed a significantly higher AIP (p < .05). The AIP was positively correlated with body mass index, the TIMI score, the Gensini score, and stent length and was effective for the diagnosis and risk assessment of patients with CTO. Multivariate logistic regression analyses revealed that the AIP was an independent risk factor for CTO. The findings suggest that the AIP could predict the presence of CTO and disease severity.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Therapeutic Index
Coronary Artery Disease I: Introduction